Back
uniQure NV Vs. ProQR Therapeutics NV Industry Stock Comparison
Sell
23
QURE
uniQure NV
Last Price:
5.78
Seasonality Move:
10.46%
Buy
51
PRQR
ProQR Therapeutics NV
Last Price:
3.63
Seasonality Move:
18.99%
Sell
23
uniQure NV (QURE)
is a Sell
Is uniQure NV a Buy, Sell or Hold?
- The current uniQure NV [QURE] share price is $5.85. The Score for QURE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- QURE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $3.61. The Score for PRQR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QURE Stock Price Chart
What is uniQure NV's stock price today?
-
The uniQure NV share price today is $5.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QURE is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $3.61
The current trend is moderately bullish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
QURE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 43.86 | Sell |
| Chaikin Money Flow: | 435453 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.89 - 7.05) | Sell |
| Bollinger Bands (100): | (5.16 - 7.62) | Sell |
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 54.31 | Buy |
| Chaikin Money Flow: | -146694 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.47 - 3.93) | Sell |
| Bollinger Bands (100): | (1.54 - 3.18) | Buy |
QURE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.25 | Sell |
| 20-day SMA: | 6.46 | Sell |
| 50-day SMA: | 5.92 | Sell |
| 200-day SMA: | 5.75 | Buy |
| 8-day EMA: | 6.17 | Sell |
| 20-day EMA: | 6.32 | Sell |
| 50-day EMA: | 6.18 | Sell |
| 200-day EMA: | 6.48 | Sell |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.78 | Sell |
| 20-day SMA: | 3.68 | Sell |
| 50-day SMA: | 2.81 | Buy |
| 200-day SMA: | 2.18 | Buy |
| 8-day EMA: | 3.7 | Sell |
| 20-day EMA: | 3.58 | Buy |
| 50-day EMA: | 3.06 | Buy |
| 200-day EMA: | 2.31 | Buy |
uniQure NV Earnings Growth & QURE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.34 per share, and an increase next year of $0.99 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
uniQure NV Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProQR Therapeutics NV Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||